Shanghai Fosun Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.81%

Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has an Asset Resilience Ratio of 1.81% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥2.23 Billion

≈ $325.77 Million USD Cash + Short-term Investments

Total Assets

CN¥122.97 Billion

≈ $17.99 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2025)

This chart shows how Shanghai Fosun Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Shanghai Fosun Pharmaceutical Group Co L's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Fosun Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Fosun Pharmaceutical Group Co L (600196) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.23 Billion	1.81%
Total Liquid Assets	CN¥2.23 Billion	1.81%

Asset Resilience Insights

Limited Liquidity: Shanghai Fosun Pharmaceutical Group Co Ltd maintains only 1.81% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Fosun Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Fosun Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Suven Pharmaceuticals Limited NSE:SUVENPHAR	Drug Manufacturers - Specialty & Generic	6.76%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Bausch Health Companies Inc TO:BHC	Drug Manufacturers - Specialty & Generic	4.97%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Changzhou Qianhong Biopharma Co Ltd SHE:002550	Drug Manufacturers - Specialty & Generic	18.70%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Shandong Lukang Pharmaceutical Co Ltd SHG:600789	Drug Manufacturers - Specialty & Generic	0.01%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Shanghai Fosun Pharmaceutical Group Co Ltd (2001–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Fosun Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.97%	CN¥5.99 Billion ≈ $875.80 Million	CN¥120.47 Billion ≈ $17.63 Billion	+2.76pp
2024-12-31	2.21%	CN¥2.60 Billion ≈ $379.88 Million	CN¥117.46 Billion ≈ $17.19 Billion	+0.55pp
2023-12-31	1.66%	CN¥1.89 Billion ≈ $276.35 Million	CN¥113.47 Billion ≈ $16.60 Billion	+0.80pp
2022-12-31	0.87%	CN¥928.53 Million ≈ $135.87 Million	CN¥107.16 Billion ≈ $15.68 Billion	-3.68pp
2021-12-31	4.55%	CN¥4.24 Billion ≈ $620.60 Million	CN¥93.29 Billion ≈ $13.65 Billion	+2.19pp
2020-12-31	2.35%	CN¥1.97 Billion ≈ $288.29 Million	CN¥83.69 Billion ≈ $12.25 Billion	+1.75pp
2019-12-31	0.60%	CN¥456.65 Million ≈ $66.82 Million	CN¥76.12 Billion ≈ $11.14 Billion	-0.27pp
2018-12-31	0.87%	CN¥616.12 Million ≈ $90.16 Million	CN¥70.55 Billion ≈ $10.32 Billion	+0.52pp
2017-12-31	0.35%	CN¥219.33 Million ≈ $32.09 Million	CN¥61.97 Billion ≈ $9.07 Billion	+0.24pp
2016-12-31	0.11%	CN¥48.49 Million ≈ $7.10 Million	CN¥43.77 Billion ≈ $6.40 Billion	+0.02pp
2015-12-31	0.09%	CN¥33.75 Million ≈ $4.94 Million	CN¥38.20 Billion ≈ $5.59 Billion	-0.01pp
2014-12-31	0.10%	CN¥33.77 Million ≈ $4.94 Million	CN¥35.34 Billion ≈ $5.17 Billion	-0.05pp
2013-12-31	0.15%	CN¥44.20 Million ≈ $6.47 Million	CN¥29.48 Billion ≈ $4.31 Billion	-0.73pp
2012-12-31	0.88%	CN¥224.83 Million ≈ $32.90 Million	CN¥25.51 Billion ≈ $3.73 Billion	-0.16pp
2011-12-31	1.04%	CN¥231.32 Million ≈ $33.85 Million	CN¥22.29 Billion ≈ $3.26 Billion	-0.26pp
2010-12-31	1.30%	CN¥218.76 Million ≈ $32.01 Million	CN¥16.82 Billion ≈ $2.46 Billion	+1.20pp
2009-12-31	0.10%	CN¥11.70 Million ≈ $1.71 Million	CN¥11.53 Billion ≈ $1.69 Billion	+0.10pp
2008-12-31	0.00%	CN¥94.32K ≈ $13.80K	CN¥7.54 Billion ≈ $1.10 Billion	-0.08pp
2007-12-31	0.08%	CN¥5.84 Million ≈ $855.13K	CN¥7.43 Billion ≈ $1.09 Billion	+0.05pp
2006-12-31	0.03%	CN¥2.11 Million ≈ $309.12K	CN¥6.63 Billion ≈ $970.75 Million	-0.07pp
2004-12-31	0.10%	CN¥5.20 Million ≈ $760.92K	CN¥5.17 Billion ≈ $756.61 Million	+0.10pp
2003-12-31	0.00%	CN¥200.00K ≈ $29.27K	CN¥4.22 Billion ≈ $617.35 Million	-9.08pp
2002-12-31	9.09%	CN¥285.35 Million ≈ $41.76 Million	CN¥3.14 Billion ≈ $459.42 Million	+9.05pp
2001-12-31	0.04%	CN¥871.98K ≈ $127.60K	CN¥2.21 Billion ≈ $323.00 Million	--

pp = percentage points

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$7.36 Billion

CN¥50.31 Billion CNY

Market Cap Rank

#2789 Global

#354 in China

Share Price

CN¥23.75

Change (1 day)

+4.35%

52-Week Range

CN¥21.21 - CN¥32.15

All Time High

CN¥85.06